Valorisation

One type of valorisation is economical. This may take place through patenting inventions and collaborations between academic researchers and companies to advance development and setting up spin-off companies.

Besides, societal valorisation may include transferring knowledge to other researchers and institutions. It can also mean ensuring the uptake of research findings in healthcare guidelines. All research results should, of course, be disseminated to other researchers in and outside the field. It is also important to communicate the results to the general public or specific interest groups, such as patients.  

Public-Private Partnerships

The LUMC stimulates valorisation of knowledge by supporting its researchers in setting up public-private partnerships. This can be done at a R&D project level, for example projects focussing on drugs against COVID-19 (PanCoroNed), or aiming to improve personalised vaccines against cancer. The LUMC also frequently collaborates in large scale collaborations.

Knowledge exchange and intellectual property

To contribute to sustainable health and health care, the LUMC aims to bring new findings to use in the clinic, in the market and society. Therefore, this is an essential part of the LUMC police. Our Technology Transfer Office Luris supports achieving this. Luris can also give you advice on protection of new knowledge, agreements with third parties, company formation and the funding opportunities for starting your own company.

For more information and contact details: visit the Knowledge Transfer Office Luris website.

Dissemination and communication

LUMC clinicians and researchers regularly organise and participate in scientific conferences to keep in contact with colleagues in the field. We also organise public events every year. Examples are the annual LUMC Open Science day (Dutch: Wetenschapsdag) and the monthly so-called PEP talk, where a LUMC scientist explains their research to interested personnel and patients.